From The Advisory Board

Liberia's Only Internist Dies of Ebola: Remembering Dr. Abraham Borbor

Liberia's Only Internist Dies of Ebola: Remembering Dr. Abraham Borbor

Dr. Burtness, a member of the Cancer Therapy Advisory Board, reflects on the loss of Dr. Abraham Borbor, the only certified internist in Liberia who recently died of Ebola.

The Promise of PD-1/PD-L1 Antagonists in Treating Metastatic Melanoma

The Promise of PD-1/PD-L1 Antagonists in Treating Metastatic Melanoma

Mario Sznol, MD, comments on the results of his phase 1 study reporting on data from patients with metastatic melanoma treated with nivolumab.

New Weapon Against Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

New Weapon Against Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

FDA approval of ramucirumab offers a new therapy option for patients with gastric cancer, which is notoriously aggressive and difficult disease to treat.

Expert Perspectives on Breast Cancer Awareness Month

Expert Perspectives on Breast Cancer Awareness Month

Editorial Board Member Don Dizon, MD, answers some questions about issues in breast cancer treatment today.

Reflections on Patient Perspectives and Survivorship from the 2013 Breast Cancer Symposium

Reflections on Patient Perspectives and Survivorship from the 2013 Breast Cancer Symposium

ChemotherapyAdvisor.com Editorial Board Member Don S. Dizon discusses survivorship issues from the 2013 Breast Cancer Symposium.

Q&A with Mark Socinski, MD, on the POINTBREAK Trial of Maintenance Therapy for NSCLC

Q&A with Mark Socinski, MD, on the POINTBREAK Trial of Maintenance Therapy for NSCLC

Editorial Advisory Board member Dr. Socinski discusses the key clinical insights brought to light by the POINTBREAK trial, presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology.

Dr. Jeffrey Farma Offers Overview of Translational Research at ASCO GI

Dr. Jeffrey Farma Offers Overview of Translational Research at ASCO GI

An expert reviews the new maintenance, second- and third-line therapies for colorectal cancer treatment presented at the 2013 Gastrointestinal Cancers Symposium.

Active Surveillance for Low-Risk Prostate Cancer May Improve Quality of Life

Active Surveillance for Low-Risk Prostate Cancer May Improve Quality of Life

In this article, Advisory Board member Neal Shore, MD, FACS, discusses barriers to clinicians recommending active surveillance for men with low-risk prostate cancer.

New Treatments for Metastatic Colorectal Cancer

New Treatments for Metastatic Colorectal Cancer

Several new therapies for metastatic colorectal cancer have been developed and refined, changing the way the disease can be treated.

Sentinel Lymph Nodes for Melanoma: To Biopsy or Not?

Sentinel Lymph Nodes for Melanoma: To Biopsy or Not?

Advisory Board Member Dr. Farma reviews the current recommendations for using sentinel lymph node biopsy in patients with melanoma.

Sign Up for Free e-newsletters

CTA Community Poll

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs